Attenuating Smac mimetic compound 3‐induced NF‐κB activation by luteolin leads to synergistic cytotoxicity in cancer cells
Authors:
- 8 September 2009
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 108 (5) , 1125-1131
Abstract
Smac mimetics are potential anticancer therapeutics selectively killing cancer cells through autocrine tumor necrosis factor (TNF)‐mediated apoptosis pathway. Our recent study reveal that the Smac mimetic compound 3 (SMC3)‐activated NF‐κB protects cancer cells against apoptosis, thus blunting SMC3's anticancer activity. Based on our previous observations that the nutrient flavonoid luteolin potently blocks TNF‐induced NF‐κB activation in cancer cells, we investigated if the combination of SMC3 and luteolin would achieve a synergistic anticancer activity. The results show that luteolin had no effect on autocrine TNF but it effectively blocked SMC3‐induced nuclear factor kappa B (NF‐κB) activation and expression of anti‐apoptotic NF‐κB targets. When SMC3 and luteolin were combined in treating cancer cells derived from lung and liver tumors, the activation of TNF‐dependent apoptosis was markedly sensitized and a synergistic cytotoxic effect was achieved. In addition, the SMC3 and luteolin co‐treatment had marginal effect on immortalized normal human bronchial epithelial cells. The results suggest that combination of SMC3 and luteolin is an effective approach for improving the anticancer value of SMC3, which has implications in cancer prevention and therapy. J. Cell. Biochem. 108: 1125–1131, 2009.Keywords
This publication has 32 references indexed in Scilit:
- IKKβ-mediated nuclear factor-κB activation attenuates smac mimetic–induced apoptosis in cancer cellsMolecular Cancer Therapeutics, 2009
- Luteolin sensitizes tumor necrosis factor-α-induced apoptosis in human tumor cellsOncogene, 2004
- Inhibition of NFκB Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer ModelsJournal of Biological Chemistry, 2004
- Tumor Necrosis Factor-induced Nonapoptotic Cell Death Requires Receptor-interacting Protein-mediated Cellular Reactive Oxygen Species AccumulationJournal of Biological Chemistry, 2004
- 2-Deoxy-d-glucose Increases the Efficacy of Adriamycin and Paclitaxel in Human Osteosarcoma and Non-Small Cell Lung Cancers In Vivo Cancer Research, 2004
- Signalling pathways of the TNF superfamily: a double-edged swordNature Reviews Immunology, 2003
- Structural and biochemical basis of apoptotic activation by Smac/DIABLONature, 2000
- Identification of DIABLO, a Mammalian Protein that Promotes Apoptosis by Binding to and Antagonizing IAP ProteinsCell, 2000
- The Hallmarks of CancerCell, 2000
- Cleavage of the death domain kinase RIP by Caspase-8 prompts TNF-induced apoptosisGenes & Development, 1999